| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Development of BTK inhibitors for the treatment of B-cell malignancies
|
Kim, Hyung-Ook
|
|
2019
|
42 |
2 |
p. 171-181
|
article
|
| 2 |
Influence of CYP2D6 genetic polymorphism on pharmacokinetics of active moiety of tolterodine
|
Byeon, Ji-Yeong
|
|
2018
|
42 |
2 |
p. 182-190
|
article
|
| 3 |
Mitochondria-centric bioenergetic characteristics in cancer stem-like cells
|
Shin, Min-Kyue
|
|
2019
|
42 |
2 |
p. 113-127
|
article
|
| 4 |
Peptide-based targeted therapeutics and apoptosis imaging probes for cancer therapy
|
Vadevoo, Sri Murugan Poongkavithai
|
|
2019
|
42 |
2 |
p. 150-158
|
article
|
| 5 |
Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 as a molecular target in breast cancer: a therapeutic perspective of gynecological cancer
|
Kim, Garam
|
|
2019
|
42 |
2 |
p. 128-139
|
article
|
| 6 |
Rab25 and RCP in cancer progression
|
Cho, Kyung Hwa
|
|
2019
|
42 |
2 |
p. 101-112
|
article
|
| 7 |
Retraction Note to: Analysis of loxoprofen in tablets, patches, and equine urine as tert-butyldimethylsilyl derivative by gas chromatography-mass spectrometry
|
Kim, Youngbae
|
|
2019
|
42 |
2 |
p. 191
|
article
|
| 8 |
Targeting cancer energy metabolism: a potential systemic cure for cancer
|
Kim, Soo-Youl
|
|
2019
|
42 |
2 |
p. 140-149
|
article
|
| 9 |
Targeting epigenetics for cancer therapy
|
Park, Jong Woo
|
|
2019
|
42 |
2 |
p. 159-170
|
article
|
Journal description